Health
Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma – News-Medical.Net
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment…
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment combination.
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen…
Continue Reading
-
General19 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News21 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News24 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
General19 hours agoTariff letters to 12 countries going out Monday: Trump